LetterLetter
Alemtuzumab (Campath-1H) for Treatment of Refractory Polymyositis
BEN THOMPSON, PAUL CORRIS, JAMES A.L. MILLER, ROBERT G. COOPER, JOHN P. HALSEY, JOHN D. ISAACS and Consultant Rheumatologist
The Journal of Rheumatology October 2008, 35 (10) 2080-2082;
BEN THOMPSON
PAUL CORRIS
JAMES A.L. MILLER
ROBERT G. COOPER
JOHN P. HALSEY
JOHN D. ISAACS
Consultant Rheumatologist
In this issue
The Journal of Rheumatology
Vol. 35, Issue 10
1 Oct 2008
Alemtuzumab (Campath-1H) for Treatment of Refractory Polymyositis
BEN THOMPSON, PAUL CORRIS, JAMES A.L. MILLER, ROBERT G. COOPER, JOHN P. HALSEY, JOHN D. ISAACS, Consultant Rheumatologist
The Journal of Rheumatology Oct 2008, 35 (10) 2080-2082;